
Ypsomed successfully completes capital increase
Ad hoc announcement pursuant to Art. 53 LR

Ypsomed announces details of capital increase
Ad hoc announcement pursuant to Art. 53 LR

Ypsomed increases sales by 15.2% and triples its operating profit
Ad hoc announcement pursuant to Art. 53 LR
Changes in the Board of Directors at Ypsomed
Ad hoc announcement pursuant to Art. 53 LR
Ypsomed, Abbott and CamDiab unveil new automated insulin delivery partnership for people with diabetes
Press Releases Ypsomed Group